Novo Nordisk or Eli Lilly? The Billion-Dollar GLP-1 Battle Is Heating Up
The global pharmaceutical industry is witnessing one of the biggest healthcare competitions in history. Two industry giants—Novo Nordisk and Eli Lilly—are …
Biotech News
AI Is Revolutionizing Drug Discovery—Here’s Why Big Pharma Is Investing Billions
Artificial Intelligence (AI) is no longer just a buzzword in the technology sector—it has become one of the most important forces …
Eli Lilly Expands U.S. Manufacturing in 2026: What It Means for GLP-1 Drugs, Pharma Jobs, and Healthcare Innovation
The demand for GLP-1 medicines used in diabetes care and, where approved, chronic weight management has grown rapidly in recent years. …
$10 Billion Pharma Deal Could Transform Rare Disease Treatments
The pharmaceutical industry has witnessed another major acquisition as Vertex Pharmaceuticals announced an agreement to acquire Crinetics Pharmaceuticals in a transaction …
Generic GLP-1 Drugs Could Change the Weight-Loss Market—FDA Begins Review
The U.S. market for GLP-1 medicines continues to expand rapidly as demand for obesity and diabetes treatments grows. In another important …
FDA Approves Sanofi’s Wearable Cancer Drug Device—A Big Step for Cancer Care
The U.S. Food and Drug Administration (FDA) has approved a wearable injector version of Sanofi’s blood cancer medicine Sarclisa for eligible …
FDA Plans to Simplify Drug Manufacturer Registration—Here’s Why It Matters
The U.S. Food and Drug Administration (FDA) has proposed a new rule that could simplify registration requirements for certain drug manufacturers …
Top 15 AI Companies Transforming Drug Discovery in 2026: The Future of Pharmaceutical Innovation
Artificial intelligence is rapidly becoming one of the most influential technologies in pharmaceutical research. What once required years of laboratory screening …
Dr. Reddy’s Semaglutide Supply Delay: What It Means for the Global GLP-1 Market in 2026
The global race to expand access to GLP-1 medicines has reached another important milestone after Dr. Reddy’s Laboratories announced a temporary …